185 related articles for article (PubMed ID: 31508314)
1. Safety and efficacy of cyclooxygenase-2 inhibition for treatment of primary hypertrophic osteoarthropathy: A single-arm intervention trial.
Yuan L; Liao RX; Lin YY; Jiang Y; Wang O; Li M; Xing XP; Pang QQ; Hsieh E; Xia WB
J Orthop Translat; 2019 Jul; 18():109-118. PubMed ID: 31508314
[TBL] [Abstract][Full Text] [Related]
2. Clinical, Biochemical, and Genetic Features of 41 Han Chinese Families With Primary Hypertrophic Osteoarthropathy, and Their Therapeutic Response to Etoricoxib: Results From a Six-Month Prospective Clinical Intervention.
Li SS; He JW; Fu WZ; Liu YJ; Hu YQ; Zhang ZL
J Bone Miner Res; 2017 Aug; 32(8):1659-1666. PubMed ID: 28425581
[TBL] [Abstract][Full Text] [Related]
3. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and phenotypic comparison between two subtypes of primary hypertrophic osteoarthropathy (PHO): A single-center study.
Hou Y; Lin Y; Qi X; Yuan L; Liao R; Pang Q; Cui L; Jiang Y; Wang O; Li M; Dong J; Xia W
Bone; 2018 Jan; 106():96-102. PubMed ID: 28963081
[TBL] [Abstract][Full Text] [Related]
4. Monoallelic mutations in SLCO2A1 cause autosomal dominant primary hypertrophic osteoarthropathy.
Xu Y; Zhang Z; Yue H; Li S; Zhang Z
J Bone Miner Res; 2021 Aug; 36(8):1459-1468. PubMed ID: 33852188
[TBL] [Abstract][Full Text] [Related]
5. Two novel mutations in the SLCO2A1 gene in a Chinese patient with primary hypertrophic osteoarthropathy.
Zhang Z; He JW; Fu WZ; Zhang CQ; Zhang ZL
Gene; 2014 Jan; 534(2):421-3. PubMed ID: 24185079
[TBL] [Abstract][Full Text] [Related]
6. The first case of primary hypertrophic osteoarthropathy with soft tissue giant tumors caused by HPGD loss-of-function mutation.
Pang Q; Xu Y; Qi X; Jiang Y; Wang O; Li M; Xing X; Qin L; Xia W
Endocr Connect; 2019 Jun; 8(6):736-744. PubMed ID: 31063976
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biochemical characteristics of 12 Chinese primary hypertrophic osteoarthropathy patients with HPGD mutations.
Lu Q; Xu Y; Li S; Zhang Z; Sheng J; Zhang Z
Int J Biol Sci; 2022; 18(9):3908-3917. PubMed ID: 35813463
[TBL] [Abstract][Full Text] [Related]
8. A Common Mutation and a Novel Mutation in the HPGD Gene in Nine Patients with Primary Hypertrophic Osteoarthropathy.
Yuan L; Chen L; Liao RX; Lin YY; Jiang Y; Wang O; Li M; Xing XP; Pang QQ; Jiajue R; Xia WB
Calcif Tissue Int; 2015 Oct; 97(4):336-42. PubMed ID: 26135126
[TBL] [Abstract][Full Text] [Related]
9. Three novel mutations in the SLCO2A1 gene in two Chinese families with primary hypertrophic osteoarthropathy.
Cheng R; Li M; Guo Y; Yao Y; Gao C; Yao Z
Eur J Dermatol; 2013; 23(5):636-9. PubMed ID: 24153155
[TBL] [Abstract][Full Text] [Related]
10. Novel SLCO2A1compound heterozygous mutation causing primary hypertrophic osteoarthropathy with Bartter-like hypokalemia in a Chinese family.
Jiang Y; Du J; Song YW; Wang WB; Pang QQ; Li M; Wang O; Lian XL; Xing XP; Xia WB
J Endocrinol Invest; 2019 Oct; 42(10):1245-1252. PubMed ID: 31004291
[TBL] [Abstract][Full Text] [Related]
11. Primary hypertrophic osteoarthropathy: genetics, clinical features and management.
Lu Q; Xu Y; Zhang Z; Li S; Zhang Z
Front Endocrinol (Lausanne); 2023; 14():1235040. PubMed ID: 37705574
[TBL] [Abstract][Full Text] [Related]
12. Touraine-Solente-Gole syndrome: pathogenic variant in SLCO2A1 presented with polyarthralgia and digital clubbing.
Nicolau R; Beirão T; Guimarães F; Aguiar F; Ganhão S; Rodrigues M; Grangeia A; Brito I
Pediatr Rheumatol Online J; 2023 May; 21(1):48. PubMed ID: 37226222
[TBL] [Abstract][Full Text] [Related]
13. Primary hypertrophic osteoarthropathy due to a novel
Mangupli R; Daly AF; Cuauro E; Camperos P; Krivoy J; Beckers A
Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28469926
[TBL] [Abstract][Full Text] [Related]
14. Novel SLCO2A1 mutations cause gender differentiated pachydermoperiostosis.
Yuan L; Chen X; Liu Z; Wu D; Lu J; Bao G; Zhang S; Wang L; Wu Y
Endocr Connect; 2018 Aug; 7(11):1116-28. PubMed ID: 30352415
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the prostaglandin transporter encoding gene SLCO2A1 cause primary hypertrophic osteoarthropathy and isolated digital clubbing.
Seifert W; Kühnisch J; Tüysüz B; Specker C; Brouwers A; Horn D
Hum Mutat; 2012 Apr; 33(4):660-4. PubMed ID: 22331663
[TBL] [Abstract][Full Text] [Related]
16. Inactivating mutation in the prostaglandin transporter gene, SLCO2A1, associated with familial digital clubbing, colon neoplasia, and NSAID resistance.
Guda K; Fink SP; Milne GL; Molyneaux N; Ravi L; Lewis SM; Dannenberg AJ; Montgomery CG; Zhang S; Willis J; Wiesner GL; Markowitz SD
Cancer Prev Res (Phila); 2014 Aug; 7(8):805-12. PubMed ID: 24838973
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization.
Zhang Z; He JW; Fu WZ; Zhang CQ; Zhang ZL
J Clin Endocrinol Metab; 2013 May; 98(5):E923-33. PubMed ID: 23509104
[TBL] [Abstract][Full Text] [Related]
18. Primary hypertrophic osteoarthropathy with digital clubbing and palmoplantar hyperhidrosis caused by 15-PGHD/HPGD loss-of-function mutations.
Bergmann C; Wobser M; Morbach H; Falkenbach A; Wittenhagen D; Lassay L; Ott H; Zerres K; Girschick HJ; Hamm H
Exp Dermatol; 2011 Jun; 20(6):531-3. PubMed ID: 21426412
[TBL] [Abstract][Full Text] [Related]
19. Novel pathogenic variants in SLCO2A1 causing autosomal dominant primary hypertrophic osteoarthropathy.
Bloch A; Couture G; Isidor B; Ricquebourg M; Bourrat E; Lipsker D; Taillan B; Combier A; Chiaverini C; Moufle F; Delobel B; Richette P; Collet C
Eur J Med Genet; 2023 Feb; 66(2):104689. PubMed ID: 36549465
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
Diggle CP; Parry DA; Logan CV; Laissue P; Rivera C; Restrepo CM; Fonseca DJ; Morgan JE; Allanore Y; Fontenay M; Wipff J; Varret M; Gibault L; Dalantaeva N; Korbonits M; Zhou B; Yuan G; Harifi G; Cefle K; Palanduz S; Akoglu H; Zwijnenburg PJ; Lichtenbelt KD; Aubry-Rozier B; Superti-Furga A; Dallapiccola B; Accadia M; Brancati F; Sheridan EG; Taylor GR; Carr IM; Johnson CA; Markham AF; Bonthron DT
Hum Mutat; 2012 Aug; 33(8):1175-81. PubMed ID: 22553128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
